7 results
Immunosuppression in Transplantation
Induction (I):
 - Basiliximab (Simulect)
 - Alemtuzumab (Campath)
 - Rituximab
 - Anti-Thymocyte Globulin (ATG)
Induction
Cyclosporine (Neoral ... #Medications #Pharmacology ... #Table #Drugs # ... #Maintenance #Management ... #Nephrology #Renal
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... five effective oral ... If needed or if oral ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
• Itraconazole oral ... • Posaconazole oral ... • Itraconazole oral ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #management #algorithm ... #pharmacology # ... #medications #table ... #decisionaid #cardiology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
transitioning to oral ... #differential #algorithm ... #management #cardiology ... #treatment #table ... icu #clinical #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
neuroexam - Oral ... event, follow ACC algorithm ... Stable patients ... one post op Cardiology ... medical and surgical management
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Please refer to the table ... Tuberculosis #TB #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology